Stan Bukofzer
Corporate Officer/Principal chez Children's Liver Disease Foundation
Profil
Stan Bukofzer currently works at Children's Liver Disease Foundation, as Founding Member.
Dr. Bukofzer also formerly worked at Abbott Laboratories, as Divisional VP & Head-Global Medical Affairs from 1998 to 2007, Assertio Therapeutics, Inc., as Chief Medical & Scientific Officer, Senior VP in 2018, Hospira, Inc., as Chief Medical Officer from 2012 to 2015, Ocera Therapeutics, Inc., as Chief Medical Officer from 2016 to 2018, Astellas Scientific & Medical Affairs, Inc., as Vice President-Scientific & Medical Affairs from 2007 to 2012, and Assertio Holdings, Inc., as Chief Scientific & Technical Officer.
Dr. Bukofzer received his doctorate degree from the University of the Witwatersrand.
Postes actifs de Stan Bukofzer
| Sociétés | Poste | Début |
|---|---|---|
| Children's Liver Disease Foundation | Corporate Officer/Principal | - |
Anciens postes connus de Stan Bukofzer
| Sociétés | Poste | Fin |
|---|---|---|
| ASSERTIO HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 30/06/2020 |
| OCERA THERAPEUTICS INC | Directeur Technique/Scientifique/R&D | 01/04/2018 |
| HOSPIRA, INC. | Directeur Technique/Scientifique/R&D | 01/01/2015 |
| Astellas Scientific & Medical Affairs, Inc. | Corporate Officer/Principal | 01/06/2012 |
| ABBOTT LABORATORIES | Directeur Technique/Scientifique/R&D | 01/01/2007 |
Formation de Stan Bukofzer
| University of the Witwatersrand | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ASSERTIO HOLDINGS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
| Children's Liver Disease Foundation | |
| Astellas Scientific & Medical Affairs, Inc. |
